CBT
Cognitive Behavioral Therapy, the Gold Standard and the Yardstick
Evidence grade varies by use. See the breakdown on the entry. Read how the Atlas grades evidence.
CBT earns a grade 5 for specific indications: it is the most extensively trialed psychotherapy, with hundreds of RCTs and Cochrane reviews supporting it as first-line for anxiety disorders, depression, OCD, insomnia (CBT-I), and eating disorders (CBT-E). The honest qualifier is that newer real-world effect sizes are smaller than early enthusiasm suggested and relapse without ongoing practice is significant. CBT is also the comparator in many trials of other interventions, which shapes how those interventions' evidence appears.
Reference only. Not medical advice.
| Treatment | Grade | Notes |
|---|---|---|
| Anxiety disorders, OCD | 5 of 5 | First-line; very strong RCT base. |
| Insomnia (CBT-I) | 5 of 5 | First-line, ahead of long-term medication. |
| Depression | 4 of 5 | Strong, but real-world effects more modest than early trials. |
| Eating disorders (CBT-E) | 4 of 5 | Leading evidence-based approach. |
What can go wrong
Generally safe. The main considerations are that exposure-based work briefly raises distress by design, that CBT requires active engagement and homework that not everyone can sustain, and that it is not a universal fit; some people and presentations respond better to other approaches. It is a treatment for clinical conditions and belongs within proper clinical care.
This is something to take to a clinician. The Atlas can tell you what is known about cbt in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
CBT is the most studied and most cross-culturally validated psychotherapy in existence, and it plays a double role in this library: it is both a treatment and the yardstick. Aaron Beck built it in 1960s America on Albert Ellis's rational emotive therapy and Joseph Wolpe's South African behavior therapy, and its core premise, that interpretation rather than events drives suffering, is explicit Stoic teaching with clear Buddhist parallels. Hundreds of randomized trials and Cochrane reviews make it first-line for anxiety, OCD, insomnia, depression, and eating disorders, a grade 5 for several of these. The honest caveat, which the entry foregrounds, is that newer real-world effect sizes are smaller than early enthusiasm implied and relapse without ongoing practice is common. Because CBT is the comparison condition in so many trials of other therapies, its own standing quietly shapes how every other intervention's evidence reads.
The most studied and most cross-culturally validated psychotherapy there is, strong enough to be the yardstick other therapies are measured against, with an honest caveat about shrinking real-world effects.
How it works
Established and proposed: CBT is thought to work by changing the maladaptive thoughts and avoidance behaviors that maintain disorders, through cognitive restructuring, behavioral activation, and exposure. The behavioral components, especially exposure and activation, have strong mechanistic support; debate continues over how much the specifically cognitive components add beyond them.
What people get wrong
Often saidCBT works equally well for everyone and every problem.
ActuallyIt is first-line for several disorders, but fit varies, real-world effects are more modest than early trials, and relapse without practice is common.
Often saidCBT is purely a Western invention with no precedent.
ActuallyIts central premise, that interpretation drives suffering, is explicit Stoic teaching and has Buddhist and other contemplative parallels long predating modern therapy.
Who profits, and who pushes back
Aaron Beck / Beck Institute
Framed CBT around identifying and testing the automatic thoughts that maintain disorders.
NICE and APA
Recommend CBT as a first-line treatment across multiple conditions.
Critical methodologists
Show real-world effect sizes have declined from early-trial estimates and relapse is common.
Cross-cultural researchers
Examine how well Western CBT protocols transfer to other cultural contexts.
Where the research comes from
Most of the published research on this comes from one place. 90% of it is from United States (origin). Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| United States (origin) | 90% |
| United Kingdom | 86% |
| Global / WHO settings | 82% |
| China and East Asia | 78% |
How we got here
CBT is a modern Western synthesis, but its core idea is old and not exclusively European. Aaron Beck developed cognitive therapy in 1960s America, building on Albert Ellis's rational emotive approach of the 1950s and on the behavior therapy that Joseph Wolpe developed in South Africa in the same decade. The underlying premise, that it is our interpretation of events rather than the events themselves that drives our suffering, is the explicit teaching of Greek and Roman Stoicism (Epictetus) and has clear parallels in Buddhist and other contemplative traditions that examine how thought shapes distress. The library notes the Stoic and contemplative antecedents rather than presenting CBT as an invention without ancestry.
Beck developed cognitive therapy in the 1960s, merging with the behavior-therapy tradition to become CBT, which accumulated an enormous trial base through the 1980s, 1990s, and 2000s and became first-line in guidelines worldwide. More recent decades brought both expansion into condition-specific protocols and a sober reassessment as better-controlled trials showed smaller, though still real, effects.
- 1950sEllis (REBT) and Wolpe (behavior therapy)
- 1960sBeck develops cognitive therapy
- 1980s-2000sVast RCT base; first-line guideline status
- 2010s-2020sReal-world effect sizes reassessed downward
How it is understood
CBT is delivered as a structured, time-limited, goal-oriented therapy in which people learn to identify and test the thoughts and behaviors that maintain distress, with homework between sessions. It has spawned condition-specific protocols (CBT-I for insomnia, CBT-E for eating disorders) and is the framework most often translated and validated across cultures.
Where scholars disagree
The dispute is not whether CBT works but how large and durable its effects are, and which ingredients matter. Effect sizes in newer, better-controlled real-world trials are smaller than the early trials suggested, partly because early studies were more enthusiastic and less rigorous. For depression, CBT's advantage over comparison conditions has narrowed, relapse without continued practice is common, and questions remain about how well protocols developed in Western settings transfer to other cultures. Separately, dismantling research asks whether the behavioral elements do most of the work, with the distinctly cognitive components adding less than the name implies.
CBT proponents and guideline bodies
CBT is a gold-standard, first-line treatment across many disorders.
What it rests onHundreds of RCTs, Cochrane reviews, and guideline endorsements for anxiety, depression, OCD, insomnia, and more.
Critical methodologists
Real-world effects are more modest than early trials implied and relapse is common.
What it rests onDeclining effect sizes in recent trials and analyses of publication and allegiance effects.
This disagreement is live. It has not settled.
At a glance
- Originator
- Aaron Beck, 1960s
- Antecedents
- Ellis (REBT), Wolpe, Stoicism
- Best evidence
- Anxiety, OCD, insomnia, depression
- Special role
- The comparator in many NPI trials
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about CBT. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What people take it for. We have not catalogued the claims made for it.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.